Risk Factors for Persistent Postural-Perceptual Dizziness Development
RIPPPDD
1 other identifier
observational
39
1 country
1
Brief Summary
The primary aim of this study is to determine whether the prevalence of neuroticism, anxiety and body vigilance is higher in patients diagnosed with PPPD compared to those who suffered a vestibular insult but did not develop PPPD and healthy controls. An increased prevalence of one or more of these factors may identify them as risk factors in the development of PPPD. The secondary aim is to understand how PPPD affects quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 9, 2019
CompletedStudy Start
First participant enrolled
April 9, 2019
CompletedFirst Posted
Study publicly available on registry
April 29, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2020
CompletedDecember 22, 2020
December 1, 2020
10 months
April 9, 2019
December 21, 2020
Conditions
Outcome Measures
Primary Outcomes (3)
Scores of the Generalised Anxiety & Depression - 7 (GAD-7) questionnaire
Average total scores of the GAD-7 will be compared across each study group. Higher scores indicate higher feelings of anxiety and/or depression in that study group. The minimum score is 0 and the maximum is 21.
1 year
Scores of the Big Five Inventory (BFI) questionnaire
Average total scores for each category of the BFI will be compared across each study group. The BFI measures five personality areas: Extraversion, Aggreableness, Conscientiousness, Neuroticism, and Openess. Minimum scores for each subcategory is 1 and the maximum is 5. Higher scores indicate a higher propensity for that personality trait.
1 year
Scores from the Body Vigilance Scale (BVS) questionnaire
Average scores for each question of the BVS will be compared across each study group. Minimum score is 0, maximum score is 10. Higher scores indicate higher body vigilance towards bodily sensations.
1 year
Secondary Outcomes (3)
Scores from the Dizziness Handicap Inventory (DHI) questionnaire
1 year
Scores from the Vertigo Symptom Scale (VSS) questionnaire
1 year
Scores from the Brief Dizziness Perception Questionnaire (DPQ)
1 year
Eligibility Criteria
All patients who have been given a previous diagnosis of PPPD will be considered as potential cases and screened for inclusion/exclusion criteria. PPPD diagnosis must be based on the CCBS criteria (Table 1). Participants will be identified by a member of the current clinical care team either through clinic notes or in the outpatient clinics.
You may qualify if:
- Must have diagnosis of PPPD based on the CCBS criteria
- Aged under 18 years old
You may not qualify if:
- No confirmed/firm diagnosis of PPPD
- Aged \<18 years old
- Unable to provide informed consent
- Current clinically significant illness that could confound the study results
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Southend Hospital
Westcliff-on-Sea, Essex, SS0 0RY, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aaron Trinidade, MBBS
CI
- STUDY DIRECTOR
Bhaskar Dasgupta, MD
R&D Director
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 9, 2019
First Posted
April 29, 2019
Study Start
April 9, 2019
Primary Completion
January 31, 2020
Study Completion
January 31, 2020
Last Updated
December 22, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share